ArticleFrontiers in immunology2023

Exploring the joint potential of inflammation, immunity, and receptor-based biomarkers for evaluating ME/CFS progression.

Uldis Berkis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.